Vivimed Labs Limited — Important, 13-06-2025: General Updates

Vivimed Labs is negotiating with bankers to settle significant loan defaults, with Rs. 57.44 Cr interest expense not accounted on accrual, understating losses. Borrowings of Rs. 374.46 Cr remain unconfirmed and all loans are NPAs. Related party transactions await confirmation, affecting audit transparency. Subsidiary investments of Rs. 58.78 Cr show potential impairment signs but no provisions made yet. Net losses have widened sharply after factoring in these unrecognized expenses, highlighting continued financial distress.